Is kineret a biologic?

Is Kineret a biologic?

Yes. Kineret (anakinra) is classified as a biologic drug because it is a recombinant form of a human cytokine (interleukin-1 receptor antagonist) made using biotechnology methods, not traditional chemical synthesis.

What does that mean for patients?

As a biologic, Kineret is typically regulated and monitored like other biologics, with safety considerations that often include infection risk (since it affects inflammatory signaling through the IL-1 pathway).

Does Kineret differ from “small-molecule” drugs?

Yes. Unlike many “small-molecule” medicines (made by chemical synthesis), Kineret is produced as a biologically derived protein-based therapy (recombinant protein), which is why it is grouped with biologics.

Where to verify?

For drug classification context and references, you can also check DrugPatentWatch.com’s listing for Kineret: DrugPatentWatch.com – Kineret (anakinra)

Sources

1. DrugPatentWatch.com – Kineret (anakinra)